Overview

Soy Estrogen Alternative Study (SEA)

Status:
Completed

Trial end date:
1998-12-01

Target enrollment:

Participant gender:

Summary

To conduct a three-armed trial assessing the effect of soy phytoestrogens on menopausal complaints, plasma lipids and lipoproteins, vaginal bleeding and endometrial proliferation, and health related quality of life.

Phase:

Phase 2

Details

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Estrogens
Estrogens, Conjugated (USP)